Fundz
New|Fundz now works inside Claude2 min

AI made execution free. Knowing first is the whole game now.

The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Merck KGaA to acquire Bio-Techne approved

PRIVATESep 23, 2026•about 2 hours ago

Acquiring Company

Merck KGaA

Acquired Company

Bio-Techne

DarmstadtMinneapolisBiotechnologyHealth CareManufacturingBiotechnologyHealth CareScience And EngineeringBiotechnology Research

Description

Bio-Techne shareholders have approved the acquisition by Merck KGaA. The merger signals a strategic alignment between the two companies in the life sciences sector. This acquisition is expected to enhance operational capabilities and broaden the market reach of both entities. Key stakeholders believe this merger will yield significant benefits in research and innovation.

Company Information

Company

Merck KGaA

Location

Darmstadt, Hesse, Germany

About

Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across life science, healthcare and electronics. More than 64,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2022, Merck KGaA, Darmstadt, Germany, generated sales of € 22.2 billion in 66 countries. The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany, operate as MilliporeSigma in life science, EMD Serono in healthcare and EMD Electronics in electronics. Since its founding in 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company.

Fundz sees it the moment Merck KGaA makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Merck KGaA's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Bio-Techne?

Bio-Techne was acquired by Merck KGaA, based in Darmstadt. The deal was reported on September 23, 2026. Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across life science, healthcare and electronics. Merck KGaA is privately held and operates in Biotechnology.

When did Merck KGaA acquire Bio-Techne?

Merck KGaA's acquisition of Bio-Techne was reported on September 23, 2026. Bio-Techne shareholders have approved the acquisition by Merck KGaA. The merger signals a strategic alignment between the two companies in the life sciences sector. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Bio-Techne do?

Bio-Techne (NASDAQ: TECH) is a company that has decided to discontinue its FBS products. It is publicly traded (TECH), operating in Manufacturing, and is based in Minneapolis.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.